These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35767725)

  • 41. Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4-amino-5-cyanopyrimidine) derivatives.
    Boualia I; Derabli C; Boulcina R; Bensouici C; Yildirim M; Birinci Yildirim A; Mokrani EH; Debache A
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900027. PubMed ID: 31448454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
    Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
    Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
    Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quinoline containing chalcone derivatives as cholinesterase inhibitors and their in silico modeling studies.
    Shah MS; Najam-Ul-Haq M; Shah HS; Farooq Rizvi SU; Iqbal J
    Comput Biol Chem; 2018 Oct; 76():310-317. PubMed ID: 30142564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A New Class of Benzo[
    Delogu GL; Begala M; Matos MJ; Crucitti D; Sogos V; Era B; Fais A
    Molecules; 2024 Aug; 29(16):. PubMed ID: 39202830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
    Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
    Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and anticholinesterase activity of new substituted benzo[d]oxazole-based derivatives.
    Pouramiri B; Moghimi S; Mahdavi M; Nadri H; Moradi A; Tavakolinejad-Kermani E; Firoozpour L; Asadipour A; Foroumadi A
    Chem Biol Drug Des; 2017 May; 89(5):783-789. PubMed ID: 27863021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis, acetylcholinesterase, butyrylcholinesterase, and amyloid-β aggregation inhibition studies of substituted 4,4'-diimine/4,4'-diazobiphenyl derivatives.
    Fidan GS; Parlar S; Tarikogullari AH; Alptuzun V; Alpan AS
    Arch Pharm (Weinheim); 2022 Dec; 355(12):e2200152. PubMed ID: 35976708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors.
    Mughal EU; Javid A; Sadiq A; Murtaza S; Zafar MN; Khan BA; Sumrra SH; Tahir MN; Kanwal ; Khan KM
    Bioorg Med Chem; 2018 Jul; 26(12):3696-3706. PubMed ID: 29886083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor.
    Gholami A; Minai-Tehrani D; Eriksson LA
    Sci Rep; 2023 Jan; 13(1):643. PubMed ID: 36635365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, Synthesis, Characterization and Computational Studies of Mannich Bases Oxadiazole Derivatives as New Class of Jack Bean Urease Inhibitors.
    Mutahir S; Khan MA; Almehizia AA; Abouzied AS; Khalifa NE; Naglah AM; Deng H; Refat MS; Khojali WMA; Huwaimel B
    Chem Biodivers; 2023 Aug; 20(8):e202300241. PubMed ID: 37344354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and evaluation of coumarin/1,2,4-oxadiazole hybrids as selective BChE inhibitors with neuroprotective activity.
    Zhang J; Li JC; Song JL; Cheng ZQ; Sun JZ; Jiang CS
    J Asian Nat Prod Res; 2019 Nov; 21(11):1090-1103. PubMed ID: 29991292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A biochemistry-oriented drug design: synthesis, anticancer activity, enzymes inhibition, molecular docking studies of novel 1,2,4-triazole derivatives.
    Yuriy K; Kusdemir G; Volodymyr P; Tüzün B; Taslimi P; Karatas OF; Anastasia K; Maryna P; Sayın K
    J Biomol Struct Dyn; 2024; 42(3):1220-1236. PubMed ID: 37671856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
    Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and evaluation of Fmoc-amino esters and amides bearing a substrate like quaternary ammonium group as selective butyrylcholinesterase inhibitors.
    Godinez J; Lee CY; Schwans JP
    Bioorg Med Chem Lett; 2023 Aug; 92():129392. PubMed ID: 37364726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.